Melanoma: all 3,073 studies

Page 12 of 31. Open to participants first (529), then studies with results posted, then the rest; newest registration first within each.

• Chemotherapy Followed by ESO-1 Lymphocytes and Aldesleukin to Treat Metastatic CancerTerminatedNCT00670748Phase 2Results posted
• Saracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By SurgeryCompletedNCT00669019Phase 2Results posted
• Study of Temzolomide and Gleevec in Advanced MelanomaTerminatedNCT00667953Phase 1/2Results posted
• Chemotherapy Followed by gp100 Lymphocytes and Aldesleukin to Treat MelanomaCompletedNCT00665470Phase 2Results posted
• Halt Growth of Liver Tumors From Uveal Melanoma With Closure of Liver Artery Following Injection of GM-CSFCompletedNCT00661622Phase 2Results posted
• Viral Therapy in Treating Patients With Metastatic MelanomaCompletedNCT00651157Phase 2Results posted
• Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III MelanomaCompletedNCT00636168Phase 3Results posted
• Bevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by SurgeryCompletedNCT00626405Phase 2Results posted
• Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain MetastasesCompletedNCT00623766Phase 2Results posted
• Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic MelanomaTerminatedNCT00613509Phase 2Results posted
• Anti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced MelanomaTerminatedNCT00612222Phase 2Results posted
• Safety and Efficacy of Combination HDI and Anti-CTLA4 for Recurrent Inoperable Stage III or Stage IV MelanomaCompletedNCT00610857Phase 2Results posted
• Anti-gp100 Cells Plus ALVAC gp100 Vaccine to Treat Advanced MelanomaTerminatedNCT00610311Phase 2Results posted
• Temozolomide and Sorafenib in Treating Patients With Metastatic or Unresectable MelanomaCompletedNCT00602576Phase 2Results posted
• Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic MelanomaCompletedNCT00598507Phase 2Results posted
• Determine Toxicity and Antibody Responses With a KLH Conjugated Bivalent Vaccine Containing GD2 Lactone, GD3 Lactone With Immunological Adjuvant QS-DG or OPT-821 in Patients With Disease Free AJCC Stage III or IV Cutaneous MelanomaCompletedNCT00597272Not applicableResults posted
• A Phase I/II Study of Dasatinib and DacarbazineCompletedNCT00597038Phase 1/2Results posted
• Treatment With Intravitreal Avastin for Large Uveal MelanomasCompletedNCT00596362Not applicableResults posted
• RAD001 Plus Bevacizumab in Metastatic MelanomaCompletedNCT00591734Phase 2Results posted
• Phase II Trial of Extended-Dosing Temozolomide in Patients With MelanomaCompletedNCT00591370Phase 2Results posted
• Pilot hu14.18-IL2 in Resectable Recurrent Stage III or Stage IV MelanomaCompletedNCT00590824Phase 2Results posted
• Phase II Trial of Neoadjuvant Temozolomide in Melanoma Patients With Palpable Stage III or IV Disease Undergoing Complete Surgical ResectionCompletedNCT00588341Phase 2Results posted
• Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain MetastasesCompletedNCT00587964Phase 2Results posted
• SU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous MelanomaCompletedNCT00577382Phase 2Results posted
• Paclitaxel and Carboplatin or Temozolomide in Treating Patients With Stage IV MelanomaTerminatedNCT00568451Phase 2Results posted
• A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and AngiogenesisCompletedNCT00565721Phase 2Results posted
• Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the BrainTerminatedNCT00550654Phase 2Results posted
• Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone MetastasesTerminatedNCT00540969Phase 3Results posted
• Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk MelanomaActive, not recruitingNCT00539591Phase 2Results posted
• A Study of IMC-1121B (Ramucirumab) With or Without Dacarbazine in Metastatic Malignant MelanomaCompletedNCT00533702Phase 2Results posted
• Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma PatientsCompletedNCT00525031Phase 2Results posted
• Phase 2 Study of Intralesional PV-10 for Metastatic MelanomaCompletedNCT00521053Phase 2Results posted
• Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by SurgeryCompletedNCT00521001Phase 2Results posted
• Study of ADI-PEG 20 in Patients With Advanced MelanomaCompletedNCT00520299Phase 1/2Results posted
• Study of NY-ESO-1 ISCOMATRIX® in Patients With Measurable Stage III or IV MelanomaCompletedNCT00518206Phase 2Results posted
• Vaccination Plus Ontak in Patients With Metastatic MelanomaTerminatedNCT00515528Phase 2Results posted
• Phase II Study of Short-Term Cultured Anti-Tumor Autologous Lymphocytes After Lymphocyte-Depleting Chemotherapy in Metastatic MelanomaCompletedNCT00513604Phase 2Results posted
• Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or MelanomaTerminatedNCT00512798Phase 1/2Results posted
• Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Anti-gp100:154-162 TCR Gene Engineered LymphocytesTerminatedNCT00509496Phase 2Results posted
• Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Infusion of Anti-MART-1 F5 TCR-Gene-Engineered LymphocytesCompletedNCT00509288Phase 2Results posted
• Safety and Efficacy of Marqibo in Metastatic Malignant Uveal MelanomaCompletedNCT00506142Phase 2Results posted
• Biochemotherapy With Temozolomide for Metastatic MelanomaTerminatedNCT00505635Phase 2Results posted
• Fibrin Melanoma Axillary Node Study in Patients With MelanomaCompletedNCT00504582Not applicableResults posted
• A Phase II, Multi-Center, Open-Label, Uncontrolled Study to Evaluate the Efficacy and Safety of Sorafenib Given Daily in Combination With Repeated 21-Day Cycles of Dacarbazine (DTIC) Chemotherapy in Subjects With Advanced Metastatic MelanomaCompletedNCT00492297Phase 2Results posted
• Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye MelanomaTerminatedNCT00482911Phase 2Results posted
• Ticilimumab (CP-675,206) in Treating Patients With Stage IIIC or Stage IV MelanomaCompletedNCT00471887Phase 2Results posted
• Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by SurgeryCompletedNCT00470470Phase 2Results posted
• Erlotinib and Bevacizumab in Treating Patients With Stage IV MelanomaCompletedNCT00466687Phase 2Results posted
• Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or MelanomaCompletedNCT00462982Phase 2Results posted
• Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II StudyCompletedNCT00462423Phase 2Results posted
• Lovastatin in Treating Patients At High Risk of MelanomaCompletedNCT00462280Phase 2Results posted
• High-Dose PEG-Intron Pharmacokinetic Study in Patients With Melanoma (Study P04831 AM2)CompletedNCT00457418Phase 1Results posted
• Pegylated Arginine Deiminase in Treating Patients With Metastatic Melanoma That Cannot Be Removed by SurgeryCompletedNCT00450372Phase 2Results posted
• VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by SurgeryCompletedNCT00450255Phase 2Results posted
• Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal CancerCompletedNCT00445965Phase 2Results posted
• A Study of MDX-1106 in Patients With Selected Refractory or Relapsed MalignanciesCompletedNCT00441337Phase 1Results posted
• Dasatinib in Treating Patients With Stage III Melanoma That Cannot Be Removed By Surgery or Stage IV MelanomaCompletedNCT00436605Phase 2Results posted
• A Study of Bevacizumab With Carboplatin and Paclitaxel Chemotherapy for the First-Line Treatment of Patients With Metastatic MelanomaCompletedNCT00434252Phase 2Results posted
• Evaluation of Pigmented Skin Lesions With MelaFind(R) SystemCompletedNCT00434057Phase 3Results posted
• A Study of Recombinant Vaccinia Virus to Treat Malignant MelanomaCompletedNCT00429312Phase 1/2Results posted
• Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic MelanomaCompletedNCT00414765Phase 4Results posted
• Palonosetron for Prevention of Biochemotherapy Induced Nausea and VomitingCompletedNCT00412425Phase 1/2Results posted
• Safety Study of PLX4032 in Patients With Solid TumorsCompletedNCT00405587Phase 1Results posted
• Carboplatin and ABI-007 in Treating Patients With Stage IV Melanoma That Cannot Be Removed By SurgeryCompletedNCT00404235Phase 2Results posted
• Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV MelanomaCompletedNCT00398073Phase 1Results posted
• Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant MelanomaCompletedNCT00397982Phase 2Results posted
• Bevacizumab and Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Malignant MelanomaCompletedNCT00387751Phase 2Results posted
• A Study of Tasisulam in Treating Participants With Malignant MelanomaCompletedNCT00383292Phase 2Results posted
• A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued.CompletedNCT00378482Phase 2Results posted
• Sorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the EyeCompletedNCT00329641Phase 2Results posted
• Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney CancerCompletedNCT00328861Phase 2Results posted
• Post-Operative Drainage Following Lymph Node DissectionCompletedNCT00324272Phase 4Results posted
• Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV MelanomaCompletedNCT00324155Phase 3Results posted
• Chemotherapy, Irradiation, Cell Infusions, and Interleukin-2 to Treat Metastatic MelanomaCompletedNCT00314106Phase 2Results posted
• RFT-5-dgA in Patients With Metastatic MelanomaCompletedNCT00314093Phase 2Results posted
• Phase I/II Study of High-Dose Calcitriol Plus Temodar for Patients With Metastatic MelanomaCompletedNCT00301067Phase 1/2Results posted
• Phase II Trial of Ontak With Metastatic MelanomaCompletedNCT00299689Phase 2Results posted
• A Study of Talimogene Laherparepvec in Stage IIIc and Stage IV Malignant MelanomaCompletedNCT00289016Phase 2Results posted
• Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By SurgeryCompletedNCT00281957Phase 2Results posted
• Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk MelanomaCompletedNCT00273910Phase 2Results posted
• Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant MelanomaCompletedNCT00256282Phase 2Results posted
• Melanoma Vaccine With Peptides and LeuprolideCompletedNCT00254397Phase 2Results posted
• A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 MelanomaCompletedNCT00246012Phase 1/2Results posted
• AZD2171 in Treating Patients With Recurrent or Stage IV MelanomaCompletedNCT00243061Phase 2Results posted
• Study of NY-ESO-1 ISCOMATRIX® in Patients With High-risk, Resected MelanomaCompletedNCT00199901Phase 2Results posted
• A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab StudiesCompletedNCT00162123Phase 2Results posted
• Immunization With 8 Peptides Mixed With CpG 7909 or Montanide ISA51 in Patients With Metastatic Cutaneous MelanomaTerminatedNCT00145158Phase 1/2Results posted
• Immunization With the MAGE-3.A1 Peptide Mixed With the Adjuvant CpG 7909 in Patients With Metastatic MelanomaTerminatedNCT00145145Phase 1/2Results posted
• Pharmacokinetic Study of Liposomal Vincristine in Patients With Malignant Melanoma & Hepatic DysfunctionCompletedNCT00145041Phase 1Results posted
• NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting)CompletedNCT00142454Phase 1Results posted
• Trial of PI-88 With Dacarbazine in Patients With Metastatic MelanomaCompletedNCT00130442Phase 2Results posted
• Vorinostat in Treating Patients With Metastatic or Unresectable MelanomaCompletedNCT00121225Phase 2Results posted
• Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV MelanomaCompletedNCT00118274Phase 1/2Results posted
• Immunotherapy of Stage III/IV Melanoma PatientsCompletedNCT00112242Phase 1Results posted
• A Treatment Combination for Patients With Unresectable Stage III or Stage IV MelanomaCompletedNCT00111007Phase 3Results posted
• Treatment for Subjects With Unresectable Stage III or Stage IV MelanomaCompletedNCT00110994Phase 2Results posted
• Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by SurgeryCompletedNCT00110019Phase 3Results posted
• Lenalidomide (Revlimid) to Treat Advanced Ocular MelanomaCompletedNCT00109005Phase 2Results posted
• FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant MelanomaTerminatedNCT00104884Phase 2Results posted
• Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in MelanomaCompletedNCT00101166Phase 2Results posted

← Melanoma overview